Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Nutex Health (NUTX) Gross Profit (2017 - 2025)

Nutex Health's Gross Profit history spans 16 years, with the latest figure at $46.1 million for Q4 2025.

  • For Q4 2025, Gross Profit fell 67.42% year-over-year to $46.1 million; the TTM value through Dec 2025 reached $444.3 million, up 126.37%, while the annual FY2025 figure was $444.3 million, 126.37% up from the prior year.
  • Gross Profit for Q4 2025 was $46.1 million at Nutex Health, down from $154.9 million in the prior quarter.
  • Across five years, Gross Profit topped out at $176.6 million in Q4 2021 and bottomed at -$26.5 million in Q3 2022.
  • The 5-year median for Gross Profit is $22.2 million (2024), against an average of $51.4 million.
  • The largest annual shift saw Gross Profit skyrocketed 73197.31% in 2021 before it crashed 134.82% in 2022.
  • A 5-year view of Gross Profit shows it stood at $176.6 million in 2021, then crashed by 99.7% to $530324.0 in 2022, then surged by 2391.55% to $13.2 million in 2023, then soared by 971.84% to $141.6 million in 2024, then plummeted by 67.42% to $46.1 million in 2025.
  • Per Business Quant, the three most recent readings for NUTX's Gross Profit are $46.1 million (Q4 2025), $154.9 million (Q3 2025), and $124.9 million (Q2 2025).